Tvardi Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Tvardi Therapeutics, Inc. (TVRD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Current Assets
Cash and Cash Equivalents31.6122.9221.49
Short-Term Investments0.000.0022.25
Cash & Short-Term Investments31.6122.9243.74
Accounts Receivable4.500.000.00
Inventory0.900.000.00
Other Current Assets0.073.240.37
Total Current Assets31.6926.1644.11
Non-Current Assets
Property, Plant & Equipment (Net)0.300.380.46
Intangible Assets0.390.450.51
Other Non-Current Assets0.020.020.02
Total Non-Current Assets0.000.840.99
Total Assets35.2027.0045.10
Current Liabilities
Accounts Payable2.191.612.41
Accrued Liabilities8.080.641.11
Other Current Liabilities2.540.000.00
Total Current Liabilities10.373.284.28
Non-Current Liabilities
Long-Term Debt30.260.280.37
Other Non-Current Liabilities0.000.000.00
Total Non-Current Liabilities44.4585.7885.87
Total Liabilities40.8389.0690.15
Stockholders' Equity
Common Stock0.020.020.02
Retained Earnings-92.24-62.84-45.49
Accumulated Other Comprehensive Income0.000.00-0.02
Additional Paid-in Capital0.000.760.45
Shares Outstanding0.009.369.36
Total Stockholders' Equity-5.63-62.06-45.05
Total Liabilities & Equity43.8327.0045.10